Lv5
870 积分 2024-07-24 加入
Inhibiting TROP2 in advanced non-small-cell lung cancer with sacituzumab govitecan, datopotamab deruxtecan, and sacituzumab tirumotecan: similarities and differences
11天前
已完结
Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
12天前
已完结
An in Vitro Assay Using Cultured Kupffer Cells Can Predict the Impact of Drug Conjugation on in Vivo Antibody Pharmacokinetics
18天前
已完结
ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer
25天前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
26天前
已完结
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates
30天前
已完结
Peptide design through binding interface mimicry with PepMimic
1个月前
已完结
Trop2, Nectin-4, and PD-L1 expression profiles in esophageal squamous cell carcinoma: Implications for combined immunotherapy and ADC targeted therapies
1个月前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
2个月前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
3个月前
已完结
皖公网安备34019202002308
